3 Growth Companies Insiders Are Betting On

In This Article:

As global markets navigate a mixed start to the year, with U.S. equities showing resilience despite recent economic data and European inflation trends influencing monetary policy discussions, investors are keeping a close eye on growth opportunities. In this environment, stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company’s operations and strategy.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Duc Giang Chemicals Group (HOSE:DGC)

31.4%

23.8%

Seojin SystemLtd (KOSDAQ:A178320)

30.9%

39.9%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.3%

Kirloskar Pneumatic (BSE:505283)

30.3%

26.3%

Laopu Gold (SEHK:6181)

36.4%

34.2%

Plenti Group (ASX:PLT)

12.8%

120.1%

Brightstar Resources (ASX:BTR)

16.2%

84.5%

Fine M-TecLTD (KOSDAQ:A441270)

17.2%

131.1%

Fulin Precision (SZSE:300432)

13.6%

66.7%

Findi (ASX:FND)

34.8%

112.9%

Click here to see the full list of 1492 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Atea

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Atea ASA offers IT infrastructure and related solutions to businesses and public sector organizations in the Nordic countries and Baltic regions, with a market cap of NOK15.79 billion.

Operations: The company's revenue segments include NOK8.28 billion from Norway, NOK12.44 billion from Sweden, NOK7.37 billion from Denmark, NOK3.62 billion from Finland, and NOK1.76 billion from the Baltics.

Insider Ownership: 29.0%

Earnings Growth Forecast: 18.9% p.a.

Atea ASA's recent share repurchase program, authorized for up to NOK 10 million, highlights insider confidence. Despite a slight decline in nine-month sales to NOK 23.97 billion, earnings per share remain stable. Forecasts suggest Atea's earnings will grow at 18.9% annually, outpacing the Norwegian market average of 8.9%. However, its dividend yield of 4.96% is not fully covered by earnings, and revenue growth is projected at a moderate pace of 8.3% per year.

OB:ATEA Earnings and Revenue Growth as at Jan 2025
OB:ATEA Earnings and Revenue Growth as at Jan 2025

Shanghai OPM Biosciences

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shanghai OPM Biosciences Co., Ltd. specializes in providing cell culture media and CDMO services both within China and internationally, with a market cap of CN¥4.15 billion.

Operations: Revenue Segments (in millions of CN¥): The company generates revenue through its offerings in cell culture media and CDMO services.